Clinical Drug Experience Knowledgebase

Acute Chest Syndrome (Phase 2)

Acute Lung Injury (Phase 2)

Adrenoleukodystrophy (Phase 3)

Amyloid Neuropathies (Phase 3)

Amyloid Neuropathies, Familial (Phase 3)

Amyloidosis (Phase 3)

Amyloidosis, Familial (Phase 3)

Anemia (Phase 2)

Anemia, Aplastic (Phase 1)

Anemia, Hemolytic (Phase 2)

Anemia, Hemolytic, Congenital (Phase 2)

Anemia, Sickle Cell (Phase 2)

Arachnodactyly (Phase 3)

Autistic Disorder (Phase 2)

Bacterial Infections (Phase 3)

Body Dysmorphic Disorders (Phase 4)

Brain Injuries (Phase 2)

Brain Injuries, Traumatic (Phase 2)

Bronchiolitis (Phase 2)

Bronchiolitis Obliterans (Phase 2)

Bronchopulmonary Dysplasia (Phase 2)

Candidiasis (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Cardiotoxicity (Phase 1)

Cerebral Hemorrhage (Phase 2)

Chagas Disease (Phase 2)

Coccidioidomycosis (Phase 2)

Coccidiosis (Phase 2)

Congenital Abnormalities (Phase 2)

Crohn Disease (Phase 3)

Cystic Fibrosis (Phase 3)

Deficiency Diseases (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Digestive System Diseases (Phase 3)

Disease (Phase 4)

Epilepsy (Phase 4)

Fanconi Anemia (Phase 1)

Fanconi Syndrome (Phase 1)

Fatty Liver (Phase 2)

Fibrosis (Phase 3)

Gastroesophageal Reflux (Phase 3)

Gastrointestinal Diseases (Phase 3)

Graft vs Host Disease (Phase 2)

Granulomatosis with Polyangiitis (Phase 3)

Guillain-Barre Syndrome (Phase 2)

Head and Neck Neoplasms (Phase 2)

Heart Defects, Congenital (Phase 1)

Hemangioendothelioma (Phase 2)

Hemangioma (Phase 2)

Hematologic Diseases (Phase 2)

Hemorrhage (Phase 2)

Hemorrhagic Fever, Ebola (Phase 2)

Hepatic Veno-Occlusive Disease (Phase 3)

Huntington Disease (Phase 3)

Hypercapnia (Phase 1)

Hypercholesterolemia (Phase 3)

Hyperlipoproteinemia Type II (Phase 3)

Hyperphagia (Phase 2)

Immunoglobulin Light-chain Amyloidosis (Phase 1)

Immunologic Deficiency Syndromes (Phase 2)

Infant, Newborn, Diseases (Phase 4)

Infections (Phase 2)

Influenza, Human (Phase 4)

Kasabach-Merritt Syndrome (Phase 2)

Kidney Diseases (Phase 3)

Lead Poisoning (Phase 3)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lipodystrophy (Phase 2)

Liver Cirrhosis (Phase 3)

Liver Cirrhosis, Biliary (Phase 3)

Long QT Syndrome (Phase 1)

Lung Diseases (Phase 2)

Lymphangioleiomyomatosis (Phase 3)

Lymphoma (Phase 2)

Lysosomal Storage Diseases (Phase 1)

Marfan Syndrome (Phase 3)

Marijuana Abuse (Phase 1)

Melanoma (Phase 1)

Mitochondrial Diseases (Phase 3)

Mood Disorders (Phase 2)

Mucopolysaccharidoses (Phase 1)

Mucopolysaccharidosis I (Phase 1)

Muscle Weakness (Phase 3)

Myasthenia Gravis (Phase 3)

Mycobacterium avium-intracellulare Infection (Phase 2)

Mycobacterium Infections (Phase 2)

Mycoses (Phase 4)

Myelodysplastic Syndromes (Phase 2)

Neoplasm Metastasis (Phase 3)

Nephrosis (Phase 3)

Nephrotic Syndrome (Phase 3)

Neurofibroma (Phase 2)

Neurofibroma, Plexiform (Phase 2)

Neurofibromatoses (Phase 2)

Neurofibromatosis 1 (Phase 2)

Nutrition Disorders (Phase 2)

Osteopetrosis (Phase 3)

Osteoporosis (Phase 2)

Persistent Vegetative State (Phase 2)

Phenylketonurias (Phase 1)

Plague (Phase 3)

Pneumonia (Phase 2)

Poisoning (Phase 3)

Polyneuropathies (Phase 3)

Prader-Willi Syndrome (Phase 2)

Respiration Disorders (Phase 2)

Respiratory Distress Syndrome (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 2)

Respiratory Insufficiency (Phase 1)

Respiratory Tract Diseases (Phase 2)

Respiratory Tract Infections (Phase 2)

Retinitis (Phase 2)

Retinitis Pigmentosa (Phase 2)

Retinopathy of Prematurity (Phase 2)

Sarcoma, Kaposi (Phase 2)

Sepsis (Phase 1)

Severe Combined Immunodeficiency (Phase 2)

Spinal Cord Compression (Phase 1)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 3)

Thalassemia (Phase 2)

Tobacco Use Disorder (Phase 2)

Tricuspid Atresia (Phase 1)

Usher Syndromes (Phase 2)

Vesico-Ureteral Reflux (Phase 3)

Virus Diseases (Phase 2)

Vitamin A Deficiency (Phase 2)

Vitamin D Deficiency (Phase 3)

Wounds and Injuries (Phase 2)